Trial intelligence / Profile preview

Ketamine for Postoperative Mood in Women Undergoing Fractional Curettage

NCT05752110Phase 4Completed

Sponsor
Istanbul Education Research Hospital
Start
Apr 2022
Primary completion
Sep 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of ketamine in mood disorder and postoperative pain (2 arms), sponsored by Istanbul Education Research Hospital. Primary endpoint: Total Mood Score (POMS). Started Apr 2022; status: completed.

02

Drugs

ketamine
03

Conditions

mood disorderpostoperative pain

Beyond the preview

Go deeper on NCT05752110.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05752110.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call